Quantitation of endogenous inhibitor of milli-CANP in Duchenne muscular dystrophy platelets and lymphocytes: Its implication in regulation

  • B. Shailaja
  • G. Jagadeesh
  • Tajamul Hussain
  • M. P. J. S. Anandaraj
Brief Communications

Abstract

With a view to gain an insight into the regulation of calcium activated neutral protease by its endogenous inhibitor, the inhibitor was quantitated in platelets and lymphocytes of Duchenne muscular dystrophy patients and controls by dot immunoblot procedure using polyclonal antibodies against the inhibitor. A two fold increase in inhibitor levels was observed in lymphocytes but no significant increase in inhibitor levels in platelets from Duchenne muscular dystrophy. These results suggest that different regulatory mechanisms of modulation of CANP operate in these two cell types in Duchenne muscular dystrophy.

Key words

Endogenous CANP inhibitor calcium activated neutral protease Duchenne muscular dystrophy 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Hoffman, E.P., Fishbeck, K.H., and Brown, Jr. R.H. (1988) Dystrophin analysis in muscle biopsies from Duchenne and Becker muscular dystrophy patients. New Engl. J. Med. 318, 1363–1368.PubMedGoogle Scholar
  2. 2.
    Lederfein, D., Levy, Z., Augier, N., Mornet, D., Morris, G., Fuchs, O., Yawffe, D. and Nudel, U. (1992) A 71-kilo dalton protein is a major product of Duchenne muscular dystrophy gene in brain and other non-muscle tissues. Poc. Natl. Acad. Sci. USA 89, 5346–5350.CrossRefGoogle Scholar
  3. 3.
    Ervasti, J.M., Ohlendieck, K., Kahl, S.D., Gaver, M.G. and Campbel, K.P. (1990) Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345, 315–319.PubMedCrossRefGoogle Scholar
  4. 4.
    Emery, A.E.H. and Burt, D. (1980) Intracellular calcium and pathogenesis and antenatal diagnosis of Duchenne muscular dystrophy. Brit. Med. J. 280, 355–357.PubMedCrossRefGoogle Scholar
  5. 5.
    Nayyar, R., Lavanya, M., Anandavalli, T.E. and Anandaraj, M.P.J.S. (1984) Calcium activated neutral protease from muscle and platelets of Duchenne muscular dystrophy cases. Clin. Chim. Acta 143, 163–168.CrossRefGoogle Scholar
  6. 6.
    Roses, A.D., Harlowing, G., Mabry, M., Nagano, Y. and Miller, S.E. (1980) Red blood cell and fibroblast membranes in Duchenne and myotonic muscular dystrophy. Muscle Nerve 3, 36–54.PubMedCrossRefGoogle Scholar
  7. 7.
    Karagol, U., Gardner-Medwin, D. and Mestaglia, F.L. (1986) Neutrophil function in DMD. J. Neurol. Sci. 73, 72–77.CrossRefGoogle Scholar
  8. 8.
    Horenstein, A.L. and Emery, A.E.H. (1980) Human lymphocyte capping in Duchenne muscular dystrophy. Neurology 30, 1330–1332.PubMedGoogle Scholar
  9. 9.
    Lechi, C., Sinigagia, D., Gazzo, P., Banadonna, G. and Jellison, M. (1988) Platelet intracellular calcium in patients with Duchenne Muscular dystrophy. Clin. Chim. Acta 177, 119–122.PubMedCrossRefGoogle Scholar
  10. 10.
    Mechler, F., Molnar, M., Balazs, M. and Matiko, J. (1989) Intracellular free calcium concentration in lymphocytes of patients with muscular dystrophies. Biochem. Biophys. Acta 1012, 227–230.PubMedCrossRefGoogle Scholar
  11. 11.
    Melloni, E. and Pontremoli, S. (1982) Cytosolic calcium dependent proteinase of human erythrocytes, formation of an enzyme natural inhibitor complex induced by Ca2+ ions. Biochem. Biophys. Res. Commun. 106, 731–740.PubMedCrossRefGoogle Scholar
  12. 12.
    Peper, R.J., Zee, T.W. and Michelson, M. (1968) Purification of lymphocytes and platelets by gradient centrifugation. J. Lab. clin. Med. 72, 842–848.Google Scholar
  13. 13.
    Lowry, C.H., Rosenbrough, N.J., Farr, A.L. and Randall, R.J. (1951) Protein measurement with folin phenol reagent. J. Biol. Chem. 193, 265–275.PubMedGoogle Scholar
  14. 14.
    Hawkes, R., Nidday, E. and Gordon, J. (1982) A dot-immunobinding assay for monoclonal and other antibodies. J. Ann. Bio. Chem. 119, 142–147.Google Scholar
  15. 15.
    Jagadeesh, G., Shailaja, B., Moses, L., Kusuma Kumari, C., Anjaneyulu, A. and Anandaraj, M.P.J.S. (1994) Importance of monitoring calcium and calcium related properties in carrier detection for Duchenne muscular dystrophy. Ind. J. Med. Res. 99, 283–288.Google Scholar
  16. 16.
    Rabbani, N., Moses, L. and Anandaraj, M.P.J.S. (1987) Calcium activated neutral protease and its endogenous inhibitor in tissues of dystrophic and Normal mice. Biochem. Medic. Metabol. Biol. 37, 282–286.CrossRefGoogle Scholar
  17. 17.
    Amala Reddy, P., Anandavalli, T.E. and Anandaraj, M.P.J.S. (1986) Calcium activated neutral proteases (milli and micro-CANP) and endogenous CANP inhibitor of muscle in Duchenne muscular dystrophy (DMD). Clin. Chim. Acta 160, 281–288.CrossRefGoogle Scholar

Copyright information

© Association of Clinical BIochemists of India 1996

Authors and Affiliations

  • B. Shailaja
    • 1
  • G. Jagadeesh
    • 1
  • Tajamul Hussain
    • 1
  • M. P. J. S. Anandaraj
    • 1
  1. 1.Institute of Genetics, Hospital of Genetic DiseasesOsmania UniversityHyderabad

Personalised recommendations